| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Medical Biochemistry and Biophysics (P.R., L.L., C.R., Y.S., M.R., K.L.), Clinical Science/Obstetrics and Gynecology (P.L., U.O.), Radiation Sciences (K.B.), and Medical Biosciences (E.L.), Umeå University, SE-901 87, Umeå, Sweden
Address all correspondence and requests for reprints to: Dr. Kui Liu, Department of Medical Biochemistry and Biophysics, Umeå University, SE-901 87, Umeå, Sweden. E-mail: kui.liu{at}medchem.umu.se.
E-cadherin is a well characterized adhesion molecule that plays a major role in epithelial cell adhesion. Based on findings that expression of E-cadherin is frequently lost in human epithelial cancers, it has been implicated as a tumor suppressor in carcinogenesis of most human epithelial cancers. However, in ovarian cancer development, our data from the current study showed that E-cadherin expression is uniquely elevated in 86.5% of benign, borderline, and malignant ovarian carcinomas irrespective of the degree of differentiation, whereas normal ovarian samples do not express E-cadherin. Thus, we hypothesize that E-cadherin may play a distinct role in the development of ovarian epithelial cancers. Using an E-cadherin-expressing ovarian cancer cell line OVCAR-3, we have demonstrated for the first time that the establishment of E-cadherin mediated cell-cell adhesions leads to the activation of Akt and MAPK. Akt activation is mediated through the activation of phosphatidylinositol 3 kinase, and both Akt and MAPK activation are mediated by an E-cadherin adhesion-induced ligand-independent activation of epidermal growth factor receptor. We have also demonstrated that suppression of E-cadherin function leads to retarded cell proliferation and reduced viability. We therefore suggest that the concurrent formation of E-cadherin adhesion and activation of downstream proliferation signals may enhance the proliferation and survival of ovarian cancer cells. Our data partly explain why E-cadherin is always expressed during ovarian tumor development and progression.
This article has been cited by other articles:
![]() |
R. Arulanandam, A. Vultur, J. Cao, E. Carefoot, B. E. Elliott, P. F. Truesdell, L. Larue, H. Feracci, and L. Raptis Cadherin-Cadherin Engagement Promotes Cell Survival via Rac1/Cdc42 and Signal Transducer and Activator of Transcription-3 Mol. Cancer Res., August 1, 2009; 7(8): 1310 - 1327. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Soto, M. Yanagisawa, L. A. Marlow, J. A. Copland, E. A. Perez, and P. Z. Anastasiadis p120 catenin induces opposing effects on tumor cell growth depending on E-cadherin expression J. Cell Biol., November 18, 2008; 183(4): 737 - 749. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Halet, P. Viard, and J. Carroll Constitutive PtdIns(3,4,5)P3 synthesis promotes the development and survival of early mammalian embryos Development, February 1, 2008; 135(3): 425 - 429. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Fournier, L. E. Campbell, P. Castagnino, W. F. Liu, B. M. Chung, V. M. Weaver, C. S. Chen, and R. K. Assoian Rac-dependent cyclin D1 gene expression regulated by cadherin- and integrin-mediated adhesion J. Cell Sci., January 15, 2008; 121(2): 226 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-G. Kang, J. M. Jenabi, J. Zhang, N. Keshelava, H. Shimada, W. A. May, T. Ng, C. P. Reynolds, T. J. Triche, and P. H.B. Sorensen E-Cadherin Cell-Cell Adhesion in Ewing Tumor Cells Mediates Suppression of Anoikis through Activation of the ErbB4 Tyrosine Kinase Cancer Res., April 1, 2007; 67(7): 3094 - 3105. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Mauro, S. Catalano, G. Bossi, M. Pellegrino, I. Barone, S. Morales, C. Giordano, V. Bartella, I. Casaburi, and S. Ando Evidences that Leptin Up-regulates E-Cadherin Expression in Breast Cancer: Effects on Tumor Growth and Progression Cancer Res., April 1, 2007; 67(7): 3412 - 3421. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Liu, C. M. Nelson, D. M. Pirone, and C. S. Chen E-cadherin engagement stimulates proliferation via Rac1 J. Cell Biol., May 8, 2006; 173(3): 431 - 441. [Abstract] [Full Text] [PDF] |
||||
![]() |
J J Peluso N-cadherin mediated cell contact inhibits germinal vesicle breakdown in mouse oocytes maintained in vitro. Reproduction, March 1, 2006; 131(3): 429 - 437. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |